Dissanayake Shehan Bharatha 4
Accession 0000899243-17-023345
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:21 PM ET
Size
25.0 KB
Accession
0000899243-17-023345
Insider Transaction Report
- Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying)
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying)
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying)
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying) - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying)
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying) - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying)
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying)
- Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+189,780$1,491,671→ 1,227,774 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−78,186→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (78,186 underlying) - Exercise of In-Money
Common Stock
2017-10-03$7.86/sh+78,186$614,542→ 513,630 total - Exercise of In-Money
Warrant (right to purchase)
2017-10-03−189,780→ 0 totalExercise: $7.86From: 2012-11-21Exp: 2017-11-21→ Common Stock (189,780 underlying)
Footnotes (2)
- [F1]These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC ("MVA Investors"), (iv) Braslyn Ltd., (v) Joe Lewis, (vi) Christopher Fuglesang, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Aaron I. Davis (collectively, the "Boxer Group"). Joseph C. Lewis is the sole indirect beneficial owner of and controls Braslyn Ltd.
- [F2]These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each of Messrs. Fuglesang, Lieberburg, Reisman, Dissanayake and Davis is a member of MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Related Parties
1- filerCIK 0001663609
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 6:21 PM ET
- Size
- 25.0 KB